HCW Biologics
HCWB
12 hedge funds and large institutions have $1.5M invested in HCW Biologics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding
Funds holding: 12 → 12 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% less capital invested
Capital invested by funds: $1.5M → $1.5M (-$1.74K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$186K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$95K |
| 3 |
BlackRock
New York
|
+$2.07K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.03K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$517 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$12.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$517 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
HighTower Advisors
Chicago,
Illinois
| $517K | +$95K | +184 | +20% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $348K | +$186K | +361 | +91% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $251K | -$517 | -1 | -0.2% |
|
|
BCM
4
Bridgeway Capital Management
Houston,
Texas
| $139K | – | – | – |
|
|
5
BlackRock
New York
| $81.7K | +$2.07K | +4 | +2% |
|
|
6
Two Sigma Investments
New York
| $61.7K | -$12.9K | -25 | -16% |
|
7
State Street
Boston,
Massachusetts
| $41.2K | – | – | – |
|
|
CAM
8
Cresset Asset Management
Chicago,
Illinois
| $33.6K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $13K | +$517 | +1 | +4% |
|
10
Morgan Stanley
New York
| $6.52K | – | – | – |
|
|
FWM
11
Focused Wealth Management
Newburgh,
New York
| $1.92K | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| $732 | +$1.03K | +2 | New |
|
13
Wells Fargo
San Francisco,
California
| $182 | – | – | – |
|
14
Bank of America
Charlotte,
North Carolina
| $80 | – | – | – |
|
HCWB Hedge Fund Activity: Q4 2022 in Review
12 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in HCW Biologics (HCWB) for Q4 2022, worth a combined $1.5M — down 0.12% from $1.5M a quarter earlier.
Fund positioning in HCWB was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $186K. The largest seller was Two Sigma Investments, cutting an estimated $12.9K.
- 12 institutional investors held HCW Biologics (HCWB) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $1.5M of HCW Biologics stock for Q4 2022, down 0.12% quarter-over-quarter.
- 1 fund opened new HCW Biologics positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest HCW Biologics buyer in Q4 2022 was Vanguard Group, an estimated $186K added.
- The largest HCW Biologics seller in Q4 2022 was Two Sigma Investments, an estimated $12.9K sold.
Based on aggregated 13F filings for Q4 2022.